Inhibitor Therapeutics, Inc. Current Federal, State and Local, Tax Expense (Benefit)
Inhibitor Therapeutics, Inc. (INTI) reported Current Federal, State and Local, Tax Expense (Benefit) of $55.11 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-29.
Discontinued › Expense Statement › Income Tax
us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit · last filed 2024-03-29
- Inhibitor Therapeutics, Inc. current federal, state and local, tax expense (benefit) for fiscal 2022 was $55.11K.
| Period end | Current Federal, State and Local, Tax Expense (Benefit) 12 month |
|---|---|
| 2022-12-31 | $55.11K 10-K · filed 2024-03-29 |